You have no items in your shopping cart.
RecombinantNAP-2/CXCL7,Human(CHO-expressed) [orb1494676]> 98% as analyzed by SDS-PAGE.
9 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg- RecombinantMPIF-1/CCL23,Human [orb1494677]
> 98% as analyzed by SDS-PAGE.
12 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg - RecombinantMPIF/CCL23(aa46-120),Human [orb1494678]
> 95% as analyzed by SDS-PAGE.
11.3 kDa, observed by reducing SDS-PAGE.
CHO
25 μg, 5 μg, 1 mg - RecombinantMIP-3α/CCL20,Human(CHO-expressed) [orb1494679]
> 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
CHO
25 μg, 5 μg, 1 mg - RecombinantMIP-1β/CCL4,Human [orb1494680]
> 95% as analyzed by SDS-PAGE and HPLC.
10-19 kDa, observed by reducing SDS-PAGE.
CHO
25 μg, 5 μg, 1 mg - RecombinantMCP-5/CCL12,Mouse [orb1494685]
> 98% as analyzed by SDS-PAGE.
9.3-11 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantMCP‑3/MARC/CCL7,Mouse [orb1494686]
> 98% as analyzed by SDS-PAGE.
8~12 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantMCP‑3/CCL7,Human(CHO-expressed) [orb1494687]
> 98% as analyzed by SDS-PAGE.
10-18 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg